Korro Bio (KRRO) Competitors $30.76 -3.63 (-10.56%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$30.82 +0.06 (+0.20%) As of 09/12/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock KRRO vs. EVO, CVAC, COLL, PHVS, LENZ, ELVN, CALT, ZYME, STOK, and UPBShould you be buying Korro Bio stock or one of its competitors? The main competitors of Korro Bio include Evotec (EVO), CureVac (CVAC), Collegium Pharmaceutical (COLL), Pharvaris (PHVS), LENZ Therapeutics (LENZ), Enliven Therapeutics (ELVN), Calliditas Therapeutics AB (publ) (CALT), Zymeworks (ZYME), Stoke Therapeutics (STOK), and Upstream Bio (UPB). These companies are all part of the "pharmaceutical products" industry. Korro Bio vs. Its Competitors Evotec CureVac Collegium Pharmaceutical Pharvaris LENZ Therapeutics Enliven Therapeutics Calliditas Therapeutics AB (publ) Zymeworks Stoke Therapeutics Upstream Bio Korro Bio (NASDAQ:KRRO) and Evotec (NASDAQ:EVO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations. Do analysts recommend KRRO or EVO? Korro Bio presently has a consensus price target of $86.83, indicating a potential upside of 182.29%. Evotec has a consensus price target of $5.40, indicating a potential upside of 55.62%. Given Korro Bio's stronger consensus rating and higher possible upside, equities research analysts plainly believe Korro Bio is more favorable than Evotec.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Korro Bio 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.29Evotec 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has better earnings & valuation, KRRO or EVO? Korro Bio has higher earnings, but lower revenue than Evotec. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKorro Bio$6.28M45.99-$83.58M-$9.75-3.15Evotec$777.33M1.59-$212.18MN/AN/A Does the media refer more to KRRO or EVO? In the previous week, Korro Bio and Korro Bio both had 3 articles in the media. Korro Bio's average media sentiment score of 1.77 beat Evotec's score of 0.92 indicating that Korro Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Korro Bio 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Evotec 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is KRRO or EVO more profitable? Korro Bio has a net margin of 0.00% compared to Evotec's net margin of -20.14%. Evotec's return on equity of -16.94% beat Korro Bio's return on equity.Company Net Margins Return on Equity Return on Assets Korro BioN/A -61.51% -42.87% Evotec -20.14%-16.94%-8.14% Which has more risk & volatility, KRRO or EVO? Korro Bio has a beta of 2.66, meaning that its share price is 166% more volatile than the S&P 500. Comparatively, Evotec has a beta of 1.72, meaning that its share price is 72% more volatile than the S&P 500. Do insiders & institutionals believe in KRRO or EVO? 13.2% of Korro Bio shares are owned by institutional investors. Comparatively, 5.8% of Evotec shares are owned by institutional investors. 4.6% of Korro Bio shares are owned by company insiders. Comparatively, 1.0% of Evotec shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryKorro Bio beats Evotec on 11 of the 14 factors compared between the two stocks. Get Korro Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KRRO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KRRO vs. The Competition Export to ExcelMetricKorro BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$322.95M$2.60B$5.85B$10.14BDividend YieldN/A56.52%5.68%4.60%P/E Ratio-3.1523.8575.3425.98Price / Sales45.99529.66514.97181.19Price / CashN/A171.1637.5660.44Price / Book1.805.3712.156.29Net Income-$83.58M$32.95M$3.29B$271.07M7 Day Performance-7.29%1.28%0.75%3.87%1 Month Performance62.49%6.09%4.82%4.88%1 Year Performance-25.75%-2.15%60.59%26.12% Korro Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KRROKorro Bio2.2378 of 5 stars$30.76-10.6%$86.83+182.3%-23.9%$322.95M$6.28M-3.1570Positive NewsEVOEvotec1.6929 of 5 stars$3.49+0.3%$5.40+54.7%+1.8%$1.24B$862.40M0.004,827CVACCureVac4.0153 of 5 stars$5.35-0.7%$6.83+27.7%+72.8%$1.21B$579.18M5.57880Short Interest ↑COLLCollegium Pharmaceutical3.6906 of 5 stars$37.75-1.5%$42.33+12.1%+2.2%$1.21B$631.45M36.30210Positive NewsPHVSPharvaris2.3579 of 5 stars$21.83-5.3%$34.00+55.7%+13.1%$1.21BN/A-6.5030LENZLENZ Therapeutics1.6337 of 5 stars$39.63-5.6%$49.60+25.2%+100.1%$1.20BN/A-20.86110Positive NewsELVNEnliven Therapeutics3.0011 of 5 stars$20.02-0.6%$41.20+105.8%-10.6%$1.19BN/A-10.0150News CoverageInsider TradeCALTCalliditas Therapeutics AB (publ)N/A$40.00flatN/AN/A$1.19B$1.60B-21.62180News CoverageZYMEZymeworks2.3813 of 5 stars$15.19+0.9%$21.43+41.1%+29.2%$1.14B$122.87M-10.13460Positive NewsSTOKStoke Therapeutics3.9448 of 5 stars$21.99+6.3%$25.57+16.3%+71.1%$1.13B$36.56M25.87100Positive NewsUPBUpstream Bio1.9794 of 5 stars$18.73-6.2%$56.50+201.7%N/A$1.08B$2.37M0.0038Positive News Related Companies and Tools Related Companies Evotec Alternatives CureVac Alternatives Collegium Pharmaceutical Alternatives Pharvaris Alternatives LENZ Therapeutics Alternatives Enliven Therapeutics Alternatives Calliditas Therapeutics AB (publ) Alternatives Zymeworks Alternatives Stoke Therapeutics Alternatives Upstream Bio Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KRRO) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Korro Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Korro Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KRRO Stock Alerts